Background and Objectives In clinical trials, the safety of drugs is summarized by the incidence
of adverse events, while post-marketing reporting systems use disproportionate reporting …

Positive and Negative Syndrome Scale (PANSS) total score is the standard primary efficacy
measure in acute treatment studies of schizophrenia. However, PANSS factors that have …

The major problem in operating an implantable radio-frequency identification (RFID) tag
embedded on an orthopedic implant is low efficiency because of metallic interference. To …

The Internet of Things describes multiple distributed systems where all (or most) everyday
items include embedded systems in order to connect to the internet. This paradigm has the …

Background and Objective Current methods are not designed to relate the incidence of
individual adverse events reported in clinical trials to the plurality of adverse events accumulated …

Drug trials for negative symptoms in schizophrenia select patients based on the severity
and stability of negative symptoms, using criteria that are not suitable for trials of acute …

Introduction Adverse event (AE) data in randomized controlled trials (RCTs) allow quantification
of a drug’s safety risk relative to placebo and comparison across medications. The …

Increasing density of wireless communication and development of radio frequency identification
(RFID) technology in particular have increased the susceptibility of patients equipped …

The Positive and Negative Syndrome Scale (PANSS) is the most widely used efficacy
measure in acute treatment studies of schizophrenia. However, interpretation of the efficacy of …

Understanding the specificity of symptom change in schizophrenia can facilitate the evaluation
antipsychotic efficacy for different symptom domains. Previous work identified a transform …